Figure 1From: Validation of the Portuguese version of the Lithium Attitudes Questionnaire (LAQ) in bipolar patients treated with lithium: cross-over studyPercent of adherent (adh) and nonadherent (noadh) patients scoring positively for each LAQ subscore. (1) resistance to prophylaxis in general; (2) denial of therapeutic effectiveness of lithium as a prophylactic agent; (3) fear of side effects (LAQ 3); (4) difficulties with the daily routine medication intake; (5) denial of the severity of the illness; (6) negative attitudes toward drugs in general; (7) lack of information about lithium prophylaxis (LAQ 7)Back to article page